Sustainability & Climate

A new K-to-career charter school pathway opens in a former public school, testing a controversial state law and a community's hopes for the future.

Black Stone Minerals maintains its $0.30 quarterly distribution, offering stability to investors as all eyes turn to its upcoming Q1 earnings report.

A new financial deal shines a light on Modeyso, a breakthrough therapy for a rare pediatric brain cancer, linking Wall Street to life-saving innovation.

A novel drug, NP137, shows unprecedented results in a Phase 1 trial, potentially making inoperable pancreatic tumors treatable and improving survival.

Breakthrough trial data shows a new device can keep donor hearts viable for longer, potentially expanding the organ pool and saving thousands on waitlists.

Just one year after its launch, Germany's first fully digital university has topped a major ranking, signaling a new era for higher education.

A new strategic partnership aims to reshape dental education by combining premier instruments and infection control with world-class clinical training.

As its leaders vie for a top entrepreneurial award, a look at how GenScript quietly became an indispensable engine for global scientific breakthroughs.

From an AI-powered undersea lab to shaping global shark laws, discover how one university is leading a multi-front battle to save our oceans.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

Hong Kong's Top Wealth Group announces major distribution deals across ten countries, forecasting a 30% revenue jump despite recent financial headwinds.

A second federal jury finds Uber responsible for a driver's assault, raising questions about its liability for over 3,000 pending cases and legal status.

A novel gene therapy using precision-guided vectors could offer a one-time treatment for wet AMD, a leading cause of blindness, freeing patients from injections.

As disposable glove and mask waste clogs landfills, a new brand-agnostic program offers businesses a simple, scalable path to responsible recycling.

An award-winning James Hardie partner expands to Wisconsin, promising to raise the standard for home exteriors with climate-tested, design-forward solutions.

A California health plan is investing millions to build homes, not hospitals, betting that stable housing is the key to solving LA's health and homeless crises.

Amid a volatile market, insurtech Openly secures major investment and expands its Allianz deal, betting its tech-driven, agent-first model can succeed.

A novel drug derived from ibogaine, DMX-1001 aims to repair brain circuits damaged by alcohol. The FDA has now cleared it for Phase 2 human trials.

The Pacific Northwest's largest dermatology practice is opening a new clinic in Issaquah, bringing comprehensive skin care to a competitive, growing market.